Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2018.474 | Randomized phase II study of combination androgen deprivation therapy (ADT) and radiotherapy in high risk prostate cancer: Stereotactic body Radiotherapy vs conventionAl IMRT to prostate and pelvic nodes (SRAM study) | Dr. POON Darren M.C. |
| 2019.528 | Stratification of Indolent Versus Aggressive Prostate Cancer plus the Determination of Druggable Gene Targets for Aggressive Prostate Cancer: A Retrospective Study Using Archival Biopsy Samples | Dr. POON Darren M.C. |
| 2019.649 | PSMA-PET guided Stereotactic Ablative Body Radiotherapy for Oligometastasis in metastatic castration-resistant prostate cancer (mCRPC) with progression on Enzalutamide (PMSABR study) |
Dr. POON Darren MC 潘明駿 |
| 2019.613 | A Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-resistant Prostate Cancer (CheckMate 7DX: CHECKpoint pathway and nivoluMAB clinical Trial Evaluation 7DX) |
Dr. POON Darren Ming Chun 潘明駿 |
| 2018.036 | A randomized, open label, multicenter Phase 2/3 study to evaluate the efficacy and safety of rogaratinib (BAY 1163877)compared to chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma who have received prior platinumcontaining chemotherapy |
Dr. POON Darren Ming Chun 潘明駿醫生 |
| 2020.055 | An Open-label, Randomized Phase 3 Study of MK-6482 Versus Everolimus in Participants with Advanced Renal Cell Carcinoma That Has Progressed After Prior PD-1/L1 and VEGF-Targeted Therapies | Dr. POON Darren Ming Chun |
| 2018.459 | Retrospective study of docetaxel-related neutropenic sepsis in metastatic hormonal-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC) |
Dr. POON Darren Ming Chun 潘明駿 |
| 2018.472 | A Phase 2, Randomized, Open-label Study of Nivolumab or Nivolumab/BMS-986205 Alone or Combined with Intravesical BCG in Participants with BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer (CheckMate 9UT: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 9UT) |
Dr. POON Darren Ming Chun 潘明駿 |
| 2019.333 | A Randomized, Double-Blind, Controlled Phase 3 Study of Cabozantinib in Combination with Nivolumab and Ipilimumab versus Nivolumab and Ipilimumab in Subjects with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma of Intermediate or Poor Risk |
Dr. POON Darren Ming Chun 潘明駿 |
| 2025.480 | Stereotactic Ablative Radiotherapy (SABR) in Renal Cell Carcinoma (RCC): International Radiosurgery Oncology Consortium for Kidney (IROCK) Prospective Registry - The IROCK Registry | Dr. POON Darren Ming Chun |
| 2016.347 | Phase II Trial of Pembrolizumab (MK-3475) in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-199) |
Dr. POON Darren Ming Chun 潘明駿醫生 |
| 2016.302 | A PHASE III, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB (ANTI−PD-L1 ANTIBODY) AS MONOTHERAPY AND IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA |
Dr. POON Darren Ming Chun 潘明駿 |
| 2011.603 | A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER | Dr. POON Darren Ming Chun |
| 2019.630 | Survival Estimate Models of Cancer Patients with Spinal Metastases: Big Data Analytics to Aid Daily Clinical Practice |
Dr. POON Darren Ming Chun 潘明駿 |
| 2017.067 | Study on Epidemiology and Clinical Features of Patients Diagnosed with Nasopharyngeal Carcinoma at less than 20 years old in Hong Kong from 1993-2012 |
Dr. POON Darren Ming Chun 潘明駿 |
| 2022.312 | Cardiovascular investigation of Coronavirus Disease 2019 (COVID-19) |
Prof. POON Ellen 潘雅欣 |
| 2026.379 | Synergistic impact of low-carbohydrate time-restricted (LCTR) diet combined with high-intensity interval exercise (HIIE) on alleviating central obesity: A comparative randomized controlled trial | Prof. Poon Eric Tsz Chun |
| 2026.357 | Comparison of the effect of Different Cooling strategies on Physiological, and Perceptual Response during Running: A randomized crossover trial | Prof. Poon Eric Tsz Chun |
| 2026.358 | Effects of menthol, and ice water mouth rinsing on high-intensity interval training physiological and perceptual responses: a randomized crossover trial | Prof. Poon Eric Tsz Chun |
| 2024.410 | Effects of High-Intensity Interval Training on Physical Fitness, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial |
Prof. POON Eric Tsz Chun Eric Tsz-chun Poon |
| 2024.355 | High-Intensity Interval Exercise and Low-Carbohydrate Diet for Glycaemic Control and Cardiovascular Fitness in Physically Inactive Adults with Prediabetes: A Comparative Randomised Trial |
Prof. POON Eric Tsz Chun 潘梓竣 |
| 2025.543 | Building Resilience Against Rising Temperature - The Effect of High-Intensity Interval Exercise (HIIE) on Heat Tolerance, Thermoregulatory Adaptation, and Physical Fitness: A Comparative Randomized Controlled Trial |
Prof. POON Eric Tsz Chun 潘梓竣 |
| 2024.529 | An innovative approach to combine intermittent dieting (INTD) with high-intensity interval exercise (HIIE) for curbing central obesity: A comparative randomized controlled trial | Prof. POON Eric Tsz Chun |
| 2007.456 | An Uncontrolled Observational Study to Monitor Vascular Access on Haemodilaysis Patients in One Single Centre | RN Poon Ka Lai |
| 2024.459 | Enhancing Cardiometabolic Health in Postnatal Women at High-Risk for Preeclampsia Through Exercise Intervention | Prof. POON Liona Chiu Yee |
| 2024.206 | The effectiveness of relaxing music during antenatal ultrasound among high-risk pregnant women to reduce antenatal anxiety. |
Prof. POON Liona Chiu Yee Chiu Yee Liona POON |
| 2025.745 | First-trimester multi-marker prediction model for spontaneous preterm birth: integrating cervicovaginal fluid biomarkers and sonographic measurement of cervical remodeling | Prof. POON Liona Chiu Yee |
| 2025.135 | A next generation point-of care urine test (CercaTestTM Red) for prediction of preeclampsia in women with suspected preeclampsia |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2026.043 | Evaluation of artificial intelligence assisted 11-14 weeks ultrasound scan | Prof. POON Liona Chiu Yee |
| 2025.438 | Optimising Postnatal Outcomes: Implementing the NuViva Programme |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2025.411 | Development and Implementation of Holistic Personalised Postpartum Care Programme for Improving Women’s Health in Hong Kong |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2024.583 | Artificial intelligence for fetal biometry: validation of a new artificial intelligence tool. International multicenter randomized controlled trial (WORLD ATELIER) | Prof. POON Liona Chiu Yee |
| 2024.544 | An state-of-art OlinkⓇ proteomics approach for preeclampsia-specific biomarker discovery in high risk preeclampsia women |
Prof. POON Liona Chiu Yee Liona Chiu Yee |
| 2024.639 | Cardiovascular changes from early pregnancy to 2-year postpartum in women with hypertensive disorders of pregnancy |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2025.549 | Biomarkers for prediction, monitoring and follow-up of pregnancy complications | Prof. POON Liona Chiu Yee |
| 2023.538 | An investigation into levels of proteins/analytes in maternal blood using Lateral Flow Immunoassays (LTFs) and Point of Care Readers (POC) for Maternal and fetal complications of Pregnancy |
Prof. POON Liona Chiu Yee Chiu Yee Liona POON |
| 2017.472 | Study on “Biomarkers in the prediction of placental complications in pregnancy from assisted reproductive technology” |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2017.473 | Study on "Evaluation of Maternal and Fetal Dopplers" |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2016.594 | Vaginal Progesterone for the Prevention of Preterm birth in Twins: A pilot randomised, factorial designed trial – ‘POPPET’ |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2017.578 | The Use of Semi-automated Blood Pressure Device for Early Detection of Preeclampsia and Home Monitoring |
Prof. POON Liona Chiu Yee 潘昭儀 |
| 2017.496 | Cervicovaginal Fluid Biomarker for the Identification of Spontaneous Preterm Birth |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2016.338 | Ultrasound-based partogram for assessment of progress in labour |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2016.292 | Maternal cardiac function in high-risk pregnancies with impaired placentation |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2017.173 | Gestational normal values of Sylvian angle at 14-36 weeks’ gestation |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2026.326 | Home Monitoring of Uterine Activity: Predictive Performance for Early Warning of Spontaneous Preterm Birth in a Prospective Cohort | Prof. POON Liona Chiu Yee |
| 2026.460 | Validation of GDM-CARE Findings in the FORECAST Cohort |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2018.622 | Genetics association and neurodevelopment in fetal congenital abnormalities |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2019.484 | Validation of Preeclampsia Detection kit (Point-of-Care test) |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2018.302 | Evaluation of aspirin non-responsiveness in preeclampsia prevention: a pharmacometabolomic approach |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2018.410 | Novel Technique for the Detection of Fetal Cells in Maternal Circulation |
Prof. POON Liona Chiu Yee 潘昭頤 |
Page 203 of 289.

